Yung-Jue Bang, MD, PhD, on Gastric Cancer: Results From the GOLD Trial

2016 ESMO Congress
Tweet this page

Yung-Jue Bang, MD, PhD, of Seoul National University Hospital, discusses phase III study findings on olaparib and paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy. (Abstract LBA25)

Advertisement

Advertisement



Advertisement